Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment.

Blood
Su ChuRavi Bhatia

Abstract

The BCR-ABL kinase inhibitor imatinib mesylate induces complete cytogenetic response (CCR) in a high proportion of chronic myelogenous leukemia (CML) patients. However, patients in CCR usually demonstrate evidence of residual BCR-ABL-positive progenitors. The mechanisms underlying persistence of small numbers of malignant progenitors in imatinib-sensitive patients are unclear. BCR-ABL kinase domain mutations affecting drug binding can lead to secondary resistance to imatinib. We show here that kinase mutations could be detected in CD34+ cells isolated from CML patients in CCR on imatinib. Most mutations seen have not been reported in previous clinical studies. Interestingly, several of the involved amino acid positions have been implicated in an in vitro mutagenesis screen. These BCR-ABL mutations were associated with varying levels of imatinib resistance. Two of 5 patients in whom mutations were detected on initial evaluation have relapsed. In addition, 4 patients in whom mutations were not initially detected, but with rising BCR-ABL mRNA levels on quantitative polymerase chain reaction (Q-PCR) analysis, had mutations detected on follow-up evaluation. We conclude that BCR-ABL kinase mutations can be detected in CD34+ cells fro...Continue Reading

References

Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Sep 22, 2001·Science·C BartheJ R Mahon
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
Jun 22, 2002·The Journal of Biological Chemistry·Amie S CorbinBrian J Druker
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Mar 26, 2003·Cell·Bhushan NagarJohn Kuriyan
Oct 10, 2003·The New England Journal of Medicine·Tim P HughesUNKNOWN International Randomised Study of Interferon versus STI571 (IRIS) Study Group
Jan 28, 2004·Cancer Research·Nicholas J DonatoShishir Shishodin
Jan 28, 2004·The Hematology Journal : the Official Journal of the European Haematology Association·Haifa-Kathrin Al-AliMichael Werner Nikolaus Deininger

❮ Previous
Next ❯

Citations

Apr 1, 2008·Current Hematologic Malignancy Reports·Paul La Rosée, Andreas Hochhaus
Apr 29, 2010·Current Hematologic Malignancy Reports·Mhairi Copland
Apr 29, 2010·Current Hematologic Malignancy Reports·Maxim Norkin, Charles A Schiffer
Sep 1, 2006·Current Hematologic Malignancy Reports·Corey Cutler, Joseph H Antin
Sep 24, 2010·Leukemia·I SlomaC J Eaves
Jan 19, 2013·Leukemia·S MustjokiUNKNOWN Nordic CML Study Group (NCMLSG)
Jul 1, 2005·Nature·Franziska MichorMartin A Nowak
Apr 4, 2008·Nature Reviews. Cancer·Michael Savona, Moshe Talpaz
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Dec 17, 2005·Leukemia·M V Blagosklonny
Dec 8, 2006·The New England Journal of Medicine·Brian J DrukerUNKNOWN IRIS Investigators
May 2, 2007·Journal of the National Cancer Institute·Xiaoyan JiangConnie Eaves
May 2, 2007·Journal of the National Cancer Institute·Margret S Rodrigues, Martin Sattler
Mar 1, 2013·Journal of the National Cancer Institute·Min ChenXiaoyan Jiang
Jan 15, 2010·Current Opinion in Hematology·Paul La Rosée, Andreas Hochhaus
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·D A LawsonO N Witte
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Warren FiskusKapil Bhalla
Aug 23, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ann CaiCatherine J Wu
Dec 16, 2010·The Journal of Clinical Investigation·Amie S CorbinBrian J Druker
Sep 4, 2013·The Journal of Clinical Investigation·Paolo NevianiDanilo Perrotti
Nov 21, 2007·Hematology·Jerald P Radich
Dec 17, 2008·Hematology·Catriona H Jamieson
Feb 12, 2014·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Shweta Srivastava, Sarjana Dutt
Dec 13, 2006·Future Oncology·Alfonso Quintás-CardamaJorge Cortes
Mar 5, 2010·EMBO Molecular Medicine·Andrea HoelblVeronika Sexl
Oct 21, 2015·Nature Reviews. Clinical Oncology·Michael W SchmittJesse J Salk
Oct 31, 2006·Leukemia & Lymphoma·Christine V Ichim, Richard A Wells

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.